MedTrace Logo

Fluorescence-Guided Optimization of Sarcoma Margins

NCT07134192 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-12-04

No results posted yet for this study

Summary

This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.

Conditions

  • Soft Tissue Sarcoma of the Trunk and Extremities
  • Sarcoma

Interventions

PROCEDURE

Fluorescent-guided Surgery

Surgical treatment of the patient group will include the administration of a fluorescent dye and intraoperatively the resection will be aided and guided by the fluorescent signal. The wound bed will be inspected, areas with fluorescent signal will be excised and obtained separately for histopathology. Patients will receive the current post-operative standard of care for sarcoma patients

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Thomas Baad-Hansen, MD, PhD · Orthopedic Surgical Department, Aarhus University Hospital

  • Christian Kveller, MD · Orthopedic Surgical Department, Aarhus University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2028-02-01
Completion
2028-03-01

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07134192 on ClinicalTrials.gov